Double polio vaccine proves most effective in study

A new double-strain polio vaccine is more effective than triple and single vaccines and means children in high-risk areas can be immunised against two key strains of the crippling virus in a single dose, scientists say. In a study in the Lancet journal on Tuesday, World Health Organisation (WHO) scientists said research on the bivalent oral polio vaccine, known as bOPV, found it induced a "significantly higher immune response" than triple vaccines.

Researcher Roland Sutter said the findings showed that the new oral vaccine, which is made for WHO vaccination programmes by various drug firms including Britain's GlaxoSmithKline and India's Panacea Biotec, would be a potent weapon in the battle to eradicate the crippling virus. "The main advantage of the bivalent is that it is so effective against type 1 and type 3 poliovirus at the same time," he told Reuters in a telephone interview. "The impact has been quite dramatic already in India and in Nigeria with cases coming down to very low levels this year." Polio, which spreads in areas with poor sanitation, attacks the nervous system and can cause irreversible paralysis within hours of infection. Children under five are the most vulnerable.